VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EVAX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EVAXEvaxion Biotech A/S
$3.31$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEVAXQuarterly Financials

Evaxion Biotech A/S (EVAX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Evaxion Biotech A/S (EVAX) quarterly income statement — complete revenue, gross profit & net income history

EVAX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue07.49M37K0122K3.02M154K51K73K00000000000
Revenue Growth %-100%148.33%-75.97%-100%67.12%---------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit07.49M37K0122K3.02M154K51K73K00000000000
Gross Margin %-100%100%-100%100%100%100%100%-----------
Gross Profit Growth %-100%148.33%-75.97%-100%67.12%---------------
Operating Expenses4.05M4.47M4.38M3.87M4.15M4.75M4.74M4.45M4.44M5.76M5.68M6.53M6.53M6.08M6.26M6.4M7.72M5.91M7.03M5.17M
OpEx % of Revenue-59.66%11829.73%-3398.36%157.37%3074.68%8719.61%6078.08%-----------
Selling, General & Admin1.19M1.38M2.21M1.71M1.59M2.13M1.98M1.61M1.86M2.93M2.74M2.45M2.31M2.02M2.15M1.59M1.5M1.5M1.92M1.28M
SG&A % of Revenue-18.38%5978.38%-1302.46%70.73%1287.66%3158.82%2553.42%-----------
Research & Development2.56M3.09M2.17M2.16M2.25M2.61M2.75M2.84M2.3M2.83M2.94M3.85M4.07M4.07M4.11M4.8M6.15M4.42M5.11M3.89M
R&D % of Revenue-41.27%5851.35%-1848.36%86.64%1787.01%5560.78%3147.95%-----------
Other Operating Expenses301K1K00302K000275K00221K142K00071K000
Operating Income-4.05M3.02M-4.34M-3.87M-4.02M-1.73M-4.58M-4.4M-4.36M-5.76M-5.68M-6.53M-6.53M-6.08M-6.26M-6.4M-7.72M-5.91M-7.03M-5.17M
Operating Margin %-40.34%-11729.73%--3298.36%-57.37%-2974.68%-8619.61%-5978.08%-----------
Operating Income Growth %-0.7%274.58%5.26%12.01%7.79%69.96%19.31%32.63%33.12%5.28%9.3%-1.97%15.49%-2.89%10.92%-23.65%-66.22%-26.19%--57.25%
EBITDA-8.29M5.71M-4.79M-1.38M-3.93M-1.65M-6.17M1.22M-4.25M-5.56M-5.69M-6.11M-5.95M-5.38M-4.72M-5.88M-7.73M-5.62M-6.99M-4.2M
EBITDA Margin %-76.24%-12932.43%--3223.98%-54.59%-4007.79%2396.08%-5820.55%-----------
EBITDA Growth %-110.64%446.81%22.47%-212.52%7.43%70.39%-8.53%120%28.64%-3.38%-20.49%-3.89%22.99%4.34%32.5%-39.9%-67.48%-22.66%--28.5%
D&A (Non-Cash Add-back)000090.75K000115K200K00571K0000000
EBIT-8.29M5.71M-4.79M-1.38M-5.61M-1.65M-6.17M1.22M-4.59M-5.69M-5.69M-6.11M-7.17M-5.38M-4.72M-5.88M-7.73M-5.62M-6.99M-4.2M
Net Interest Income-3.79M1.33M-211K2.1M119.16K-300.95K-184K5.37M-418K-110K-174K-41K-524.2K168K1.31M361K672.2K237K-462K675K
Interest Income-4.91M2.69M30K2.49M573.95K84.26K41K5.62M-250K72K47K285K70.56K703K1.54M519K744.01K288K33K972K
Interest Expense-1.12M1.36M241K397K454.79K385.21K225K246K168K182K221K326K594.77K535K225K158K71.81K51K495K297K
Other Income/Expense-2.12M1.33M-686K2.1M120K-300K-1.82M5.37M-336K-110K-231K90K-520K168K1.31M361K674K237K-462K675K
Pretax Income-6.17M4.35M-5.03M-1.77M-3.9M-2.03M-6.4M976K-4.7M-5.87M-5.91M-6.43M-7.04M-5.92M-4.95M-6.04M-7.05M-5.67M-7.49M-4.5M
Pretax Margin %-58.09%-13583.78%--3200%-67.32%-4153.9%1913.73%-6438.36%-----------
Income Tax-256K-265K-195K-192K-275K-96K-199K-218K-177K-194K-225K-194K-173K-175K-177K-247K1.32M-425K-669K-407K
Effective Tax Rate %4.15%-6.09%3.88%10.84%7.04%4.73%3.11%-22.34%3.77%3.3%3.81%3.01%2.46%2.96%3.58%4.09%-18.77%7.49%8.93%9.04%
Net Income-5.92M4.62M-4.83M-1.58M-3.63M-1.94M-6.2M1.19M-4.52M-5.68M-5.68M-6.24M-6.87M-5.74M-4.77M-5.79M-8.37M-5.25M-6.82M-4.09M
Net Margin %-61.64%-13056.76%--2974.59%-64.14%-4024.68%2341.18%-6195.89%-----------
Net Income Growth %-63.08%338.66%22.06%-232.33%19.77%65.92%-9.06%119.13%34.18%1.08%-19.19%-7.77%17.9%-9.33%30.08%-41.49%-96.29%-30.92%--32.07%
Net Income (Continuing)-5.92M4.62M-4.83M-1.58M-3.63M-1.94M-6.2M1.19M-4.52M-5.68M-5.68M-6.24M-6.87M-5.74M-4.77M-5.79M-8.37M-5.25M-6.82M-4.09M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.894.20-4.40-0.50-3.40-1.40-4.601.04-6.60-8.20-8.40-9.68-11.40-9.64-8.00-10.00-15.44-10.92-14.40-9.20
EPS Growth %73.82%400%4.35%-148.08%48.48%82.93%45.24%110.74%42.11%14.94%-5%3.2%26.17%11.72%44.44%-8.7%-46.77%-10.08%--42.86%
EPS (Basic)-0.894.20-4.40-1.43-3.40-1.40-4.601.04-6.60-8.20-8.40-9.68-11.40-9.64-8.20-10.00-15.44-10.92-14.40-9.20
Diluted Shares Outstanding6.41M1.11M1.11M1.11M1.07M1.38M1.35M1.17M683.39K691.5K676.55K644.6K603.49K595.84K596K579.1K541.78K479.97K473.54K444.89K
Basic Shares Outstanding6.41M1.11M1.11M1.11M1.07M1.38M1.35M1.17M683.39K691.5K676.55K644.6K603.49K595.84K580.1K579.1K541.78K479.97K473.54K444.89K
Dividend Payout Ratio--------------------